Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
16.06.24 | AstraZeneca's Calquence Combo Cuts Progression Risk By 27% In Mantle Cell Lymphoma Trial | 805 | AFX News | LONDON (dpa-AFX) - AstraZeneca Plc. (AZN.L) said that results from the ECHO Phase III trial showed the company's Calquence (acalabrutinib) in combination with bendamustine and rituximab demonstrated... ► Artikel lesen | |
16.06.24 | Roche: Phase III Study Of Columvi Combo Extends Survival In Relapsed Diffuse Large B-Cell Lymphoma | 908 | AFX News | SOUTH SAN FRANCISCO (dpa-AFX) - Roche (RHHBY) announced statistically significant and clinically meaningful results from its Phase III STARGLO study of Columvi (glofitamab) in combination with... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 400 |
EVOTEC | 221 |
TESLA | 208 |
RHEINMETALL | 200 |
NOVO NORDISK | 181 |
BYD | 164 |
BAYER | 125 |
RENK GROUP | 121 |
DEUTZ | 106 |
DEUTSCHE BANK | 99 |
STEYR MOTORS | 92 |
PLUG POWER | 85 |
TUI | 85 |
ALMONTY | 83 |
SIEMENS ENERGY | 81 |
VOLKSWAGEN | 78 |
BASF | 77 |
NEL | 73 |
AMAZON | 71 |
APPLE | 71 |
THYSSENKRUPP | 70 |
XIAOMI | 69 |
MERCEDES-BENZ | 67 |
COMMERZBANK | 63 |
LITHIUM ENERGI EXPLORATION | 63 |